［1］ 中国抗癌协会妇科肿瘤专业委员会.子宫颈癌诊断与治疗指南(2021年版)［J］.中国癌症杂志，2021，31(6)：474-489.
Chinese Anti-Cancer Association Gynecologic Oncology Committee.Cervic cancer diagnosis and treatment guidelines（2021 edition)［J］.Chin J Cancer，2021，31(6)：474-489.
［2］ 林雨璇,孔为民,王元景,等.放射治疗在宫颈癌治疗中的应用与更新［J］.中国全科医学，2022，25(18)：2367-2371.
LIN YX，KONG WM，WANG YJ，et al.Application and update of radiotherapy in the treatment of cervical cancer［J］.Chin Gen Prac，2022，25(18)：2367-2371.
［3］ APPELT AL，KERKHOF EM，NYVANG L，et al.Robust dose planning objectives for mesorectal radiotherapy of early stage rectal cancer-A multicentre dose planning study［J］.Tech Innov Patient Support Radiat Oncol，2019，11：14-21.
［4］ KAVANAGH BD，PAN CC，DAWSON LA，et al.Radiation dose-volume effects in the stomach and small bowel［J］.Int J Radiat Oncol Biol Phys，2010，76(3 Suppl)：S101-S107.
［5］ SHELLEY LEA，SUTCLIFFE MPF，THOMAS SJ，et al.Associations between voxel-level accumulated dose and rectal toxicity in prostate radiotherapy［J］.Phys Imaging Radiat Oncol，2020，14：87-94.
［6］ LUKOVIC J，HOSNI A，LIU A，et al.Evaluation of dosimetric predictors of toxicity after IMRT with concurrent chemotherapy for anal cancer［J］.Radiother Oncol，2023，178：109429.
［7］BAI W，KOU C，YU W，et al.Dosimetric comparison of volumetric-modulated arc therapy and intensity-modulated radiation therapy in patients with cervical cancer：a meta-analysis［J］.Onco Targets Ther，2018,11:7179-7186.
［8］ COZZI L，DINSHAW KA，SHRIVASTAVA SK，et al.A treatment planning study comparing volumetric arc modulation with RapidArc an fixed field IMRT for cervix uteri radiotherapy［J］.Radiotheroncol,2008，89：180-191.
［9］ DENG X，HAN C，CHEN S，et al.Dosimetric benefits of intensity-modulated radiotherapy and volumetric-modulated arc therapy in the treatment of postoperative cervical cancer patients［J］.J Appl Clin Med Phys，2017，18：25-31.
［10］ BRENNAN VS，CURRAN B，SKOUROU C，et al.A novel dynamic arc treatment planning solution to reduce dose to small bowel in preoperative radiotherapy for rectal cancer［J］.Medical Dosimetry，2019，44(3)：258-265.
［11］ 郑莲容，黎桂华,朱志鹏.宫颈癌患者四种容积旋转调强计划小肠的剂量学比较［J］.影像研究与医学应用，2022，6(15)：34-37.
ZHENG LR，LI GH，ZHU ZP.Dosimetric comparison on small bowel among four VMAT plans in cervical cancer radiotherapy［J］.Journal of Imaging Research and Medical Applications，2022，6(15)：34-37.
［12］ 孙彦泽,周钢,钱建军,等.宫颈癌放疗计划中小肠3种勾画方法比较［J］.中华放射肿瘤学杂志，2016，25(1):67-70.
SUN YZ，ZHOU G，QIAN JJ，et al.The comparison of three bowel delineation strategies in the radiation therapy of cervical cancer［J］.Chin J Radiat Oncol，2016，25(1):67-70.
［13］ 许碧纯,郭旗,钱建军，等.盆腔肿瘤调强与三维适形放疗肠道勾画与剂量-体积限制的研究进展［J］.中华放射医学与防护杂志，2021,41(4):315-320.
XU BC，GUO Q，QIAN JJ，et al.Advances in bowel delineation and dose-volume constraint in intensity modulated radiation therapy and 3D conformal radiation therapy for pelvic tumors［J］.Chin J Radiol Med Prot，2021，41(4):315-320.
［14］ JADON R，HIGGINS E，HANNA L，et al.A systematic review of dose-volume predictors and constraints for late bowel toxicity following pelvic radiotherapy［J］.Radiat Oncol，2019，14：57.
［15］ YU PC，WU C，NIEN HH，et al.Tangent-based volumetric modulated arc therapy for advanced left breast cancer［J］.Radiat Onco，2018，13：236.
［16］ ROSSI M，BOMAN E，KAPANEN M.Contralateral tissue sparing in lymph node-positive breast cancer radiotherapy with VMAT technique［J］.Medical Dosimetry，2019，44(2)：117-121.
［17］ CHAN RW，PODGORSAK MB.Ipsilateral kidney sparing in treatment of pancreatic malignancies using volumetric-modulated arc therapy avoidance sectors［J］.Medical Dosimetry，2015，40(3):175-180.
［18］ PURSLEY J，DAMATO AL，CZERMINSKA MA，et al.A comparative study of standard intensity-modulated radiotherapy and RapidArc planning techniques for ipsilateral and bilateral head and neck irradiation［J］.Medical Dosimetry，2017，42(1):31-36.
［19］彭倩,骆科林,谢朝，等.两种容积旋转调强方法在局部晚期直肠癌术前放疗的剂量学比较［J］.实用医院临床杂志,2017，14(5)：40-43.
PENG Q，LUO KL，XIE Z，et al.Dosimetric comparison of two RapidArc delivery strategies in preoperative short-course radiotherapy for locally advanced rectal cancer［J］.Practical Journal of Clinical Medicine，2017，14(5)：40-43.
［20］ MELL LK，SCHOMAS DA，SALAMA JK，et al.Association between bone marrow dosimetric parameters and acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy［J］.Int J Radiat Oncol Biol Phys，2008，70(5)：1431-1437.
［21］ ALBUQUERQUE K，GIANGRECO D，MORRISON C，et al.Radiation-related predictors of hematologic toxicity after concurrent chemoradiation for cervical cancer and implications for bone marrow-sparing pelvic IMRT［J］.Int J Radiat Oncol Biol Phys，2011，79(4)：1043-1047.
［22］ CORBEAU A，KUIPERS SC，BOER SM，et al.Correlations between bone marrow radiation dose and hematologic toxicity in locally advanced cervical cancer patients receiving chemoradiation with cisplatin：a systematic review［J］.Radiotheroncol，2021，164:128-137.
［23］ ZHANG BZ，LI Y，XU LM，et al.The relationship between the radiation dose of pelvic-bone marrow and lymphocytic toxicity in concurrent chemoradiotherapy for cervical cancer［J］.Radiat Oncol,2023,18(1):12.